Health Policy

Snowflake vs. Tempus AI: Data Ownership in Healthcare’s Future

Listen to this article · 7 min listen

The healthcare AI field is splitting in two. On one side are platforms built on general data clouds, and on the other, those built on healthcare-native data strategies. This is a fundamental divergence in architectural philosophy that directly affects data ownership, clinical utility, and how we even define an “AI-native” health company. For anyone buying healthcare AI, you have to understand this foundational difference when you’re looking at solutions that promise to make care better and improve the P&L.

Innovaccer and Snowflake: A General Cloud Approach to Enterprise AI

Innovaccer’s recorded page announces its partnership with Snowflake, framing their push for enterprise AI in healthcare as a cloud infrastructure decision. The collaboration puts a general data cloud, Snowflake, at the bottom of the stack for building and deploying AI solutions, with the stated goal being faster AI adoption, better care delivery, improved operations, and healthier finances. This partnership is still active, with Innovaccer using Snowflake’s Data Cloud for its applications. For a potential buyer, this positions the whole AI adoption question as a cloud decision, leaning on the known scalability and flexibility of a general-purpose platform. Snowflake is already well-established in data warehousing, data lakes, data engineering, and secure sharing across many other industries. Innovaccer is trying to apply these general capabilities to healthcare, banking on a strong, widely used cloud infrastructure to support its AI products. The appeal is obvious, especially for a hospital system that’s already using or thinking about a general cloud strategy for the rest of its enterprise tech.

General Data Cloud Versus Healthcare-Native Stack: A Data Strategy Decision

Choosing between building healthcare AI on a general data cloud or a healthcare-native stack is the core data strategy decision. A general data cloud has its advantages in infrastructure and scalability, and it can be cost-effective for a lot of things, but it wasn’t designed for the unique regulatory, privacy, and semantic chaos of healthcare data. This data is sensitive, locked down by rules like HIPAA, and usually fragmented across dozens of systems and formats. HHS HIPAA guidance on protected health information A healthcare-native stack, on the other hand, is built from the ground up for these exact problems. That means it has specialized data models, security and privacy controls baked into every layer (not bolted on), and a built-in understanding of clinical workflows. This difference matters for what this publication calls AI-native health companies, which are defined by having their product, data pipeline, and business model all built around AI from day one, trained on real patient outcomes data, and operating with clinical guardrails and published evidence. The underlying data strategy directly determines if a company can even meet that definition. When an AI platform just sits on a general data cloud, the job of ensuring healthcare compliance, semantic interoperability, and clinical relevance gets pushed onto the application layer or, worse, back onto the healthcare organization itself. Sure, general clouds offer security features, but figuring out how to apply them to meet specific healthcare rules, like the NIST SP 800-66r2 for health information systems, can get very complicated and require a ton of custom work. NIST SP 800-66 Revision 2 was just finalized in February 2024 and gives guidance for implementing the HIPAA Security Rule. NIST Special Publication 800-66r2 for health information security

The Recorded Dataset Bar Recorded for Tempus AI

The recorded material for Tempus AI shows the other side of the coin and defines what this site considers the real AI-native architecture moat: an owned, healthcare-specific data strategy called the “Recorded Dataset.” This isn’t just a database. It’s a proprietary, curated collection of multimodal real-world data, clinical notes, molecular data, imaging, that Tempus AI has structured specifically for developing healthcare AI. Tempus AI keeps expanding this dataset. For instance, it announced an initiative in September 2026 to build a research platform with 100,000 whole genomes linked to longitudinal clinical information, with a goal to eventually reach one million genomes. This whole approach is about creating and owning a deeply contextualized, high-quality dataset as the core competitive advantage. The value of the “Recorded Dataset” is its quality and clinical relevance, not just its sheer volume, along with the rigorous process for collecting, annotating, and ethically using it. This owned data strategy is the “AI-native architecture moat,” and it suggests that real AI-nativity in healthcare depends on direct control and specialized management of the data foundation. The “Recorded Dataset” sets a high bar. It implies that for AI to actually be useful in a clinical setting, it needs training on data that reflects the full complexity of patient outcomes, collected inside a framework designed only for healthcare. This is a world away from using general data clouds which, while powerful, don’t inherently provide the specialized data governance and rich context needed for serious healthcare AI.

What the Partnership Page Does Not Record About Data Ownership

The Innovaccer and Snowflake partnership page talks a good game, using outcome language about accelerating AI adoption, enhancing care, and improving financial performance. What it doesn’t do is spell out what this architectural choice means for the platform’s data strategy, especially around data ownership and the tricky responsibilities that pop up when patient data lives on a general data cloud. For anyone looking to buy healthcare AI, this omission is a big deal. When an AI platform is built on a general cloud, who really holds the healthcare data strategy? The vendor (Innovaccer) can say it manages the AI application, but the underlying infrastructure (Snowflake) is a generic service provider. This can create serious ambiguity about who has ultimate control, governance, and long-term strategic value from the data. Set against the “Recorded Dataset” material from Tempus AI, the Innovaccer and Snowflake page shows a clear difference in philosophy. The “Recorded Dataset” model puts an owned and deeply integrated data strategy at the center of everything. Using a general data cloud might offer reach, but it leaves the critical question of healthcare data ownership unsettled in a way that is at odds with the whole idea of an AI-native architecture moat. A smart buyer has to ask: who, at the end of the day, owns our healthcare data strategy when the infrastructure is a generalist in agentic AI healthcare, and what does that mean for data provenance, future utility, and our ability to innovate from our own proprietary, clinically rich datasets? General explanation of data ownership in cloud computing

Frequently Asked Questions

What is the fundamental difference between general data clouds and healthcare-native data strategies for AI?

The fundamental difference lies in their architectural philosophy and how they address healthcare’s unique complexities. General data clouds offer broad infrastructure and scalability but are not inherently designed for healthcare’s regulatory, privacy, and semantic challenges. Healthcare-native stacks are built from the ground up with specialized data models, embedded security, and an understanding of clinical workflows.

What are the implications for data ownership and compliance when using a general data cloud for healthcare AI?

When using a general data cloud, the responsibility for ensuring healthcare data compliance, semantic interoperability, and clinical relevance often falls heavily on the application layer or the healthcare organization. While general clouds offer security features, interpreting and applying them to meet specific healthcare regulations like HIPAA can be complex and require significant customization.

What defines an ‘AI-native architecture moat’ in healthcare, according to the article?

An ‘AI-native architecture moat’ is defined by an owned, healthcare-specific data strategy, like Tempus AI’s ‘Recorded Dataset’. This involves a proprietary collection of multimodal real-world data meticulously curated and structured specifically for healthcare AI development, emphasizing quality, clinical relevance, and rigorous ethical processes.

How does a healthcare-native data strategy impact the clinical utility and efficacy of AI solutions?

A healthcare-native data strategy directly influences an AI company’s ability to build AI solutions trained on real patient outcomes data, operating within defined clinical guardrails, and having published evidence of efficacy. This approach ensures the AI is trained on data that accurately reflects the complexities of real patient outcomes, leading to more transformative and clinically useful applications.

Share
Was this article helpful?

Editorial Team

The Editorial Team at AI-Native Health Companies is a group of writers and editors who cover health, workplace wellness, and everyday care. They research each story and publish under a shared desk byline — experts in their fields, working as one team.